CNS clinical trials suicidality and data collection : workshop summary
"The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience...
| Main Author: | |
|---|---|
| Corporate Authors: | , |
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Washington, D.C.
National Academies Press
2010, c2010
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references (p. 43-49)
- Perspectives from the FDA, academia, and patients
- Data collection and optimization
- Data analysis
- Partnerships, opportunities, collaboration